Table 3.
Summary of characteristics and clinical outcomes of kidney transplant recipients with COVID-19 who continued to use immunosuppressants during hospitalization
| Patients by Age Groups, n (%) | ||||||
|---|---|---|---|---|---|---|
| Clinical Information | All Patients | ≤39 Years | 40-49 Years | 50-59 Years | 60-69 Years | ≥70 Years |
| Total No. of patients | 89 (100%) | 20 (100%) | 12 (100%) | 24 (100%) | 16 (100%) | 17 (100%) |
| No. of patients with a positive outcome | 42 (47.2%) | 17 (85%) | 5 (41.7%) | 11 (45.8%) | 4 (25%) | 5 (29.4%) |
| No. of patients who remain in hospitals | 32 (35.9%) | 3 (15%) | 7 (58.3%) | 8 (33.3%) | 10 (62.5%) | 4 (23.5%) |
| No. of patients who died | 15 (16.9%) | 0 | 0 | 5 (20.8%) | 2 (12.5%) | 8 (47.1%) |
| No. of patients without comorbidity | 24 (100%) | 12 (100%) | 3 (100%) | 2 (100%) | 3 (100%) | 4 (100%) |
| No. of patients without comorbidity and who died | 2 (8%) | 0 | 0 | 0 | 0 | 2 (40%) |
| No. of patients with at least 1 comorbidity | 65 (100%) | 10 (100%) | 8 (100%) | 22 (100%) | 13 (100%) | 12 (100) |
| No. of patients with comorbidity and who died | 13 (20%) | 0 | 0 | 5 (22.7%) | 2 (15.4%) | 6 (50%) |
| No. of patients without secondary complication | 77 (100%) | 17 (100%) | 11 (100%) | 22 (100%) | 12 (100%) | 12 (100%) |
| No. of patient without secondary complication and who died | 12 (15.6%) | 0 | 0 | 4 (18.2%) | 2 (16.7%) | 6 (35.3%) |
| No. of patients with a secondary complication | 12 (13.5%) | 3 (15%) | 1 (8.3%) | 1 (4.2%) | 4 (25%) | 3 (17.6%) |
| No. of patients with a secondary complication and who died | 3 (15.6%) | 0 | 0 | 1 (4.2%) | 0 | 2 (66.7%) |
| No. of patients without ICU care and/or ventilation | 74 (100%) | 21 (100%) | 10 (100%) | 17 (100%) | 12 (100%) | 14 (100%) |
| No of patients without ICU care and/or ventilation and who died | 10 (13.5%) | 0 | 0 | 2 (11.8%) | 2 (16.7%) | 6 (42.8%) |
| No. of patients with ICU care and/or ventilation | 15 (100%) | 1 (100%) | 2 (100% | 7 (100%) | 2 (100%) | 3 (100%) |
| No. of patients with ICU care and/or ventilation and who died | 5 (33.3%) | 0 | 0 | 3 (42.9%) | 0 | 2 (66.7%) |
| No. of female patients | 22(100%) | 7 (100%) | 1 (100%) | 4 (100%) | 4 (100%) | 6 (100%) |
| No. of female patients who died | 5 (21.7%) | 0 | 0 | 1 (25%) | 1 (25%) | 3 (50%) |
| No. of male patients | 67 (100%) | 13 (100%) | 11 (100%) | 20 (100%) | 12 (100%) | 11 (100%) |
| No. of male patients who died | 10 (15.2%) | 0 | 0 | 4 (20%) | 1 (8.3%) | 5 (45.5%) |